ARQT: Growth Matures but ZORYVE Compounding Still Intact
Arcutis has doubled in a year on accelerating ZORYVE sales and encouraging guidance. Revenue upside is in the numbers — 2026 net product sales guidance of $455-470M implies rapid compounding, but valuation (EV/sales ~11x) already prices a lot of the story. This trade targets further multiple expansion into secular adoption while protecting capital …